Minocycline augmentation in older adults with persistent depression: an open label proof of concept study
Authors:
Open Access
- 21 July 2020
- journal article
- research article
- Published by Elsevier in International Psychogeriatrics
- Vol. 32 (7) , 881-884
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Efficacy and tolerability of minocycline for depression: A systematic review and meta-analysis of clinical trialsJournal of Affective Disorders, 2018
- Young microglia restore amyloid plaque clearance of aged microgliaThe EMBO Journal, 2016
- Minocycline inhibits neurogenic inflammation by blocking the effects of tumor necrosis factor‐αClinical and Experimental Pharmacology and Physiology, 2015
- Low-grade inflammation differentiates between symptoms of apathy and depression in community-dwelling older individualsInternational Psychogeriatrics, 2014
- Cognitive/affective and somatic/affective symptom dimensions of depression are associated with current and future inflammation in heart failure patientsJournal of Affective Disorders, 2012
- Molecular signatures of peripheral blood mononuclear cells during chronic interferon-α treatment: relationship with depression and fatiguePsychological Medicine, 2011
- The inflammation hypothesis in geriatric depressionInternational Journal of Geriatric Psychiatry, 2011
- Immune Activation in Brain Aging and Neurodegeneration: Too Much or Too Little?Neuron, 2009
- Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brainNeuropathology and Applied Neurobiology, 2009
- Neuroinflammation Associated with Aging Sensitizes the Brain to the Effects of Infection or StressNeuroimmunomodulation, 2008